欧洲联合政策:精神障碍患者的COVID-19风险——伞状综述及基于证据与共识的精神卫生与公共卫生建议
该伞状综述检索Web of Science、PubMed和Ovid/PsycINFO至2022年1月17日,纳入4个系统综述/Meta分析组合、1个Meta分析和3个系统综述,每项最多包含28项原始研究,评估「任何精神障碍」和「严重精神障碍」患者COVID-19感染、住院、ICU入住和死亡风险。研究质量评为中至低,证据从高度提示到无统计学意义不等,但一致发现精神疾病患者感染、住院和死亡风险增加,ICU入住风险未增加。作者据此提出22条建议,以克服精神障碍患者在COVID-19预防和管理中的障碍。
要点
- 精神障碍患者COVID-19感染、住院和死亡风险增加,但ICU入住风险未增加。
- 证据质量评为中至低,证据从高度提示到无统计学意义不等。
- 风险负担在严重精神障碍患者中尤为突出,不能再被忽视。
- 作者提出22条建议,旨在克服精神障碍患者预防和管理COVID-19的障碍。
- 需采取紧急、有针对性和持续的行动。
适用人群与场景
- 精神障碍患者,包括「任何精神障碍」和「严重精神障碍」两类人群。
处置流程与药物剂量
- 作者提出22条建议,以克服精神障碍患者在COVID-19预防和管理中可能遇到的障碍,并定义最佳治疗选择和当前研究重点。
研究设计与关键结果
- 研究类型为伞状综述,纳入4个系统综述/Meta分析组合、1个Meta分析和3个系统综述,每项最多包含28项原始研究。
- 研究质量采用AMSTAR-2评估,质量评为中至低,证据从高度提示到无统计学意义不等。
- 一致发现精神疾病患者COVID-19感染、住院和死亡风险增加,但ICU入住风险未增加。
证据类型、等级与局限
- 证据类型:伞状综述(纳入Meta分析和系统综述)。
- 研究质量评为中至低,证据从高度提示到无统计学意义不等。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为精神障碍患者,尤其是严重精神障碍患者,COVID-19风险和负担不能再被忽视,需采取紧急、有针对性和持续的行动。
- 作者提出22条建议以促进上述行动。
指南或共识出处
- 原文为发表于Eur Psychiatry的欧洲联合政策文件,标题为「Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health」。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
As COVID-19 becomes endemic, identifying vulnerable population groups for severe infection outcomes and defining rapid and effective preventive and therapeutic strategies remains a public health priority. We performed an umbrella review, including comprehensive studies (meta-analyses and systematic reviews) investigating COVID-19 risk for infection, hospitalization, intensive care unit (ICU) admission, and mortality in people with psychiatric disorders, and outlined evidence- and consensus-based recommendations for overcoming potential barriers that psychiatric patients may experience in preventing and managing COVID-19, and defining optimal therapeutic options and current research priorities in psychiatry. We searched Web of Science, PubMed, and Ovid/PsycINFO databases up to 17 January 2022 for the umbrella review. We synthesized evidence, extracting when available pooled odd ratio estimates for the categories "any mental disorder" and "severe mental disorders." The quality of each study was assessed using the AMSTAR-2 approach and ranking evidence quality. We identified four systematic review/meta-analysis combinations, one meta-analysis, and three systematic reviews, each including up to 28 original studies. Although we rated the quality of studies from moderate to low and the evidence ranged from highly suggestive to non-significant, we found consistent evidence that people with mental illness are at increased risk of COVID-19 infection, hospitalization, and most importantly mortality, but not of ICU admission. The risk and the burden of COVID-19 in people with mental disorders, in particular those with severe mental illness, can no longer be ignored but demands urgent targeted and persistent action. Twenty-two recommendations are proposed to facilitate this process.
参考来源
- Vai B, Mazza MG, Marisa CD, et al. Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health. Eur Psychiatry. 2022. PMID: 35971656. doi:10.1192/j.eurpsy.2022.2307
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。